Preserved myocardial [123I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism: first case report

Mov Disord. 2005 May;20(5):634-6. doi: 10.1002/mds.20384.

Abstract

A decrease in myocardial uptake of iodine-123-labeled metaiodobenzylguanidine (123I-MIBG) has been reported in idiopathic Parkinson's disease (PD) using 123I-MIBG myocardial scintigraphy. However, the patient with autosomal recessive juvenile parkinsonism (AR-JP), caused by the parkin gene, presented here showed normal 123I-MIBG myocardial uptake, suggesting that AR-JP is a distinct disease entity from PD. Although the clinical features of AR-JP are sometimes quite similar to those of late-onset idiopathic PD, 123I-MIBG myocardial scintigraphy may be a powerful tool to differentiate PD from other parkinsonian syndromes, including AR-JP.

Publication types

  • Case Reports

MeSH terms

  • 3-Iodobenzylguanidine / pharmacokinetics*
  • Exons / genetics
  • Humans
  • Male
  • Middle Aged
  • Myocardium / metabolism*
  • Parkinsonian Disorders / diagnostic imaging*
  • Parkinsonian Disorders / genetics*
  • Radionuclide Imaging
  • Radiopharmaceuticals / pharmacokinetics*

Substances

  • Radiopharmaceuticals
  • 3-Iodobenzylguanidine